CSPC PHARMACEUT.GR. ADR4 (CVGU) — Cash Flow Quality Index
CSPC PHARMACEUT.GR. ADR4 (CVGU) has a Cash Flow Quality Index of 1.50x as of December 2025. Operating cash flow of €5.83 Billion exceeds net income of €3.88 Billion, indicating high earnings quality where cash backs reported profits. Explore CSPC PHARMACEUT.GR. ADR4 cash conversion from operations to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
CSPC PHARMACEUT.GR. ADR4 Cash Flow Quality Index (2021–2025)
Historical Cash Flow Quality Index for CSPC PHARMACEUT.GR. ADR4 across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check how aggressively does CSPC PHARMACEUT.GR. ADR4 reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for CSPC PHARMACEUT.GR. ADR4 (2021–2025)
Year-by-year earnings quality comparison for CSPC PHARMACEUT.GR. ADR4. For live market cap and the full company financial profile, see market cap of CSPC PHARMACEUT.GR. ADR4.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.50x | €5.83 Billion | €3.88 Billion | ▲ +53.4% |
| 2024 | 0.98x | €4.53 Billion | €4.63 Billion | ▲ +49.5% |
| 2023 | 0.65x | €4.18 Billion | €6.38 Billion | ▼ -40.3% |
| 2022 | 1.10x | €7.63 Billion | €6.95 Billion | ▲ +63.4% |
| 2021 | 0.67x | €4.64 Billion | €6.90 Billion | — |